| __timestamp | Amicus Therapeutics, Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 24419536 |
| Thursday, January 1, 2015 | 47269000 | 34718089 |
| Friday, January 1, 2016 | 71151000 | 40998209 |
| Sunday, January 1, 2017 | 88671000 | 32022880 |
| Monday, January 1, 2018 | 127200000 | 19110051 |
| Tuesday, January 1, 2019 | 169861000 | 26556257 |
| Wednesday, January 1, 2020 | 156407000 | 52275890 |
| Friday, January 1, 2021 | 192710000 | 80981000 |
| Saturday, January 1, 2022 | 213041000 | 124431000 |
| Sunday, January 1, 2023 | 275270000 | 90932000 |
| Monday, January 1, 2024 | 98761000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Amicus Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Amicus Therapeutics has seen a significant increase in SG&A expenses, growing by over 1,200% from 2014 to 2023. In contrast, Arrowhead Pharmaceuticals experienced a more modest rise of approximately 300% during the same timeframe.
The data reveals that Amicus Therapeutics consistently outspent Arrowhead Pharmaceuticals, with a peak in 2023 where their expenses were nearly three times higher. This trend highlights Amicus's aggressive investment in administrative and sales functions, possibly reflecting a strategy to expand market presence. Meanwhile, Arrowhead's steadier growth in expenses suggests a more conservative approach. Notably, data for 2024 is incomplete, indicating potential changes in future trends.
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc. Trends and Insights
GSK plc vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Viridian Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.